D.A. Davidson & Co. Takeda Pharmaceutical CO LTD Transaction History

D.A. Davidson & Co.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $174,752 - $185,044	-10,721 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$16.55 - $18.64 $57,759 - $65,053	-3,490 Reduced 24.56%	10,721 $180,000
Q1 2021 May 07, 2021	BUY	$16.71 - $19.9 $237,465 - $282,798	14,211 New	14,211 $259,000
Q2 2020 Aug 10, 2020	SELL	$14.59 - $19.5 $289,319 - $386,685	-19,830 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$13.02 - $20.31 $36,846 - $57,477	-2,830 Reduced 12.49%	19,830 $301,000
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $29,455 - $36,348	1,745 Added 8.34%	22,660 $447,000
Q3 2019 Nov 05, 2019	SELL	$16.15 - $17.99 $253,409 - $282,281	-15,691 Reduced 42.86%	20,915 $360,000
Q2 2019 Aug 13, 2019	SELL	$16.58 - $20.49 $36,989 - $45,713	-2,231 Reduced 5.74%	36,606 $648,000
Q1 2019 May 13, 2019	BUY	$16.7 - $21.52 $648,577 - $835,772	38,837 New	38,837 $791,000

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.